Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateTimeSourceHeadlineSymbolCompany
17/06/202208:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
17/06/202208:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
17/06/202208:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
17/06/202208:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
16/06/202207:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
13/06/202213:56TipRanksEvercore ISI Thinks Intellia Therapeutics’ Stock is Going to RecoverNASDAQ:NTLAIntellia Therapeutics Inc
08/06/202221:30GlobeNewswire Inc.Intellia Therapeutics to Present Updated Interim Clinical Data from Ongoing Phase 1 Study of NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis at the International Liver Congress™ 2022NASDAQ:NTLAIntellia Therapeutics Inc
10/05/202222:26TipRanksInvesting in These 3 Healthcare Stocks Could Double Your Money, Says Credit SuisseNASDAQ:NTLAIntellia Therapeutics Inc
09/05/202221:52TipRanksBrookline Capital Markets Thinks Intellia Therapeutics’ Stock is Going to RecoverNASDAQ:NTLAIntellia Therapeutics Inc
09/05/202216:23TipRanks3 Analyst’s Top Stocks with Huge Upside PotentialNASDAQ:NTLAIntellia Therapeutics Inc
09/05/202201:11TipRanksIntellia Therapeutics (NTLA) Receives a Buy from SVB SecuritiesNASDAQ:NTLAIntellia Therapeutics Inc
07/05/202213:28TipRanksIntellia Therapeutics (NTLA) Gets a Hold Rating from Robert W. BairdNASDAQ:NTLAIntellia Therapeutics Inc
07/05/202213:05TipRanksAnalysts Conflicted on These Healthcare Names: Cigna (CI), Intellia Therapeutics (NTLA) and Dynavax (DVAX)NASDAQ:NTLAIntellia Therapeutics Inc
07/05/202211:48TipRanksRBC Capital Thinks Intellia Therapeutics’ Stock is Going to RecoverNASDAQ:NTLAIntellia Therapeutics Inc
06/05/202222:32TipRanksRaymond James Thinks Intellia Therapeutics’ Stock is Going to RecoverNASDAQ:NTLAIntellia Therapeutics Inc
06/05/202210:45TipRanksChardan Capital Thinks Intellia Therapeutics’ Stock is Going to RecoverNASDAQ:NTLAIntellia Therapeutics Inc
06/05/202206:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
05/05/202221:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
05/05/202221:30GlobeNewswire Inc.Intellia Therapeutics Announces First Quarter 2022 Financial Results and Highlights Recent Company ProgressNASDAQ:NTLAIntellia Therapeutics Inc
04/05/202214:55TipRanksJMP Securities Thinks Intellia Therapeutics’ Stock is Going to RecoverNASDAQ:NTLAIntellia Therapeutics Inc
04/05/202200:20TipRanksBrookline Capital Markets Thinks Intellia Therapeutics’ Stock is Going to RecoverNASDAQ:NTLAIntellia Therapeutics Inc
03/05/202206:01GlobeNewswire Inc.Intellia Therapeutics Names Muna Bhanji, R.Ph., to its Board of DirectorsNASDAQ:NTLAIntellia Therapeutics Inc
02/05/202221:30GlobeNewswire Inc.Intellia Therapeutics Presents Preclinical Data Demonstrating Advancements in its CRISPR-Engineered Allogeneic Platform at the 2022 Keystone Symposia’s Precision Genome Engineering ConferenceNASDAQ:NTLAIntellia Therapeutics Inc
28/04/202221:30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2022 Earnings and Company UpdatesNASDAQ:NTLAIntellia Therapeutics Inc
21/03/202215:25TipRanksJMP Securities Reiterates Their Buy Rating on Intellia Therapeutics (NTLA)NASDAQ:NTLAIntellia Therapeutics Inc
10/03/202221:37TipRanksFDA Grants Orphan Drug Designation for Intellia’s NTLA-5001; Shares UpNASDAQ:NTLAIntellia Therapeutics Inc
10/03/202208:53Dow Jones NewsIntellia Therapeutics Gets FDA Orphan Drug Designation for Acute Myeloid Leukemia TreatmentNASDAQ:NTLAIntellia Therapeutics Inc
10/03/202208:01GlobeNewswire Inc.Intellia Therapeutics Receives U.S. FDA Orphan Drug Designation for NTLA-5001 for the Treatment of Acute Myeloid Leukemia NASDAQ:NTLAIntellia Therapeutics Inc
05/03/202209:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
05/03/202209:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA